Tag Archives: BDE

Top 10 Warren Buffett Stocks To Buy Right Now

Dear Reader,

More men die of jealousy than die of cancer, said Joseph Kennedy.

Today, a brief reflection on that ignoble but staggeringly human emotion

It is said a man is jealous of his betters.

But it is only partly true.

The average man harbors no jealousy for the great man.

He is not jealous of the Alexanders the Caesars the Napoleons of this world.

These are men stamped from a finer metal and the average man gracefully acknowledges it is not his metal.

The sparrow understands its place is not among the eagles.

No, the subject of the average mans jealousy is his peer the average man.

The average man is not jealous of the (19972010) Tiger Woods who won 14 majors but the guy in his weekend foursome who once broke 80.

He is not jealous of the Brad Pitt who scores the supermodel but the insurance salesman who lands the pleasant-looking gal he himself set his cap for.

Nor is the average man jealous of a Warren Buffett with his billions but the middle-class fellow down the street whos moving up to a nicer neighborhood.

Top 10 Warren Buffett Stocks To Buy Right Now: Diamondrock Hospitality Company(DRH)

Advisors’ Opinion:

  • [By Monica Gerson]

    DiamondRock Hospitality Company (NYSE: DRH) is projected to post its quarterly earnings at $0.18 per share on revenue of $218.42 million.

    Weyerhaeuser Co (NYSE: WY) is expected to report its quarterly earnings at $0.20 per share.

Top 10 Warren Buffett Stocks To Buy Right Now: 58.com Inc.(WUBA)

Advisors’ Opinion:

  • [By ]

    Then theres 58.com Inc. (NASDAQ:WUBA), the Craigslist of China. This stock exceeded our wildest expectations when we jumped into a trade in late June. After beating earnings expectations, shares rallied double-digits and didnt look back. We were able to unload the trade for gains north of 50%.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is expected to report quarterly earnings at $1.38 per share on revenue of $9.86 billion.
    Aecom (NYSE: ACM) is projected to report quarterly earnings at $0.71 per share on revenue of $4.67 billion.
    JD.Com Inc(ADR) (NASDAQ: JD) is estimated to report quarterly earnings at $0.11 per share on revenue of $12.60 billion.
    58.com Inc (ADR) (NYSE: WUBA) is projected to report quarterly earnings at $0.28 per share on revenue of $383.60 million.
    Kamada Ltd (NASDAQ: KMDA) is expected to report quarterly earnings at $0.02 per share on revenue of $25.00 million.
    Palatin Technologies, Inc. (NYSE: PTN) is projected to report quarterly earnings at $0.06 per share on revenue of $28.00 million.
    TheStreet, Inc. (NASDAQ: TST) is estimated to report a quarterly loss at $0.02 per share on revenue of $15.81 million.
    Atlantica Yield PLC (NASDAQ: ABY) is projected to report quarterly earnings at $0.45 per share on revenue of $290.80 million.
    Asure Software Inc (NASDAQ: ASUR) is estimated to report quarterly earnings at $0.15 per share on revenue of $15.26 million.
    Cyren Ltd (NASDAQ: CYRN) is expected to report quarterly loss at $0.06 per share on revenue of $7.90 million.
    Viewray Inc (NASDAQ: VRAY) is estimated to report quarterly loss at $0.12 per share on revenue of $18.58 million.

     

Top 10 Warren Buffett Stocks To Buy Right Now: SandRidge Mississippian Trust II(SDR)

Advisors’ Opinion:

  • [By Paul Ausick]

    Sandridge Mississippian Trust II (NYSE: SDR) dropped about 18% Monday to post a new 52-week low of $0.75 after closing at $0.95 on Friday. The 52-week high is $1.79. Volume was around 1.3 million, more than nine times the daily average of around 160,000. The company had no specific news.

Top 10 Warren Buffett Stocks To Buy Right Now: WGL Holdings Inc(WGL)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Brean Capital reported on Friday that it has upgraded natural gas utility company WGL Holdings Inc (WGL).

    The firm has raised its rating on WGL from “Hold” to “Buy,” and has given the company a $46 price target. This price target suggests a 12% increase from the stock’s current price of $40.62. The upgrade was primarily based on valuation and future investment opportunities.

    “Like many utilities in the gas LDC space, the shares of WGL Holdings have come off recent highs and are now trading at a level we consider attractive,” analyst Michael Gaugler comments. “Beyond valuation, we consider the recent announcement of conditional approval of Dominion’s Cove Point facility for LNG export as a positive development in terms of future investment opportunities, given the company’s one-third interest in the Commonwealth Pipeline project, which we believe will be revisited due to future increased demand.”

    WGL Holdings shares were mostly flat during pre-market trading Friday. The stock has been mostly flat YTD.

Top 10 Warren Buffett Stocks To Buy Right Now: Black Diamond, Inc.(BDE)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the week, our Under the Radar Moversnewsletter suggested small cap sporting & outdoor goods stock Black Diamond Inc (NASDAQ: BDE) as a short/bearish trade:

Top 10 Warren Buffett Stocks To Buy Right Now: Smith & Nephew SNATS, Inc.(SNN)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Charles Carlson, CEO and Portfolio Manager, Horizon Investment Services]

    For investors looking for growth but also income, I especially like three health-care related stocksFresenius Medical (FMS), Novo Nordisk (NVO), and Smith & Nephew (SNN).

  • [By Benzinga News Desk]

    Weight Watchers (NYSE: WTW) is tipping the scales on Wall Street: Link

    ECONOMIC DATA
    USA Nonfarm Payrolls for Apr 164.0K vs 189.0K Est; Prior 103.0K. Private Payrolls for Apr 168.0K vs 194.0K Est; Prior 102.0K
    Unemployment Rate for Apr 3.90% vs 4.00% Est; Prior 4.10%
    New York Fed President William Dudley is set to speak at 12:45 p.m. ET.
    The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET.
    Federal Reserve Bank of San Francisco President John Williams will speak at 3:00 p.m. ET.
    Randal Quarles, Vice Chairman for Supervision, is set to speak at 5:30 p.m. ET.
    Dallas Fed President Robert Kaplan will speak at 8:00 p.m. ET.
    Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 8:00 p.m. ET.
    Kansas City Fed President Esther George will speak at 8:00 p.m. ET.
    ANALYST RATINGS
    RBC upgraded Benefitfocus (NASDAQ: BNFT) from Sector Perform to Outperform
    Stephens upgraded FMC (NYSE: FMC) from Equal-Weight to Overweight
    RBC downgraded Colfax (NYSE: CFX) from Outperform to Sector Perform
    Deutsche Bank downgraded Smith & Nephew (NYSE: SNN) from Hold to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Top 10 Warren Buffett Stocks To Buy Right Now: China Automotive Systems, Inc.(CAAS)

Advisors’ Opinion:

  • [By Monica Gerson]

    China Automotive Systems, Inc. (NASDAQ: CAAS) is projected to post its quarterly earnings at $0.20 per share on revenue of $108.22 million.

    Affimed NV (NASDAQ: AFMD) is projected to post a quarterly loss at $0.18 per share on revenue of $1.71 million.

  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Brokerages Expect China Automotive Systems (CAAS) to Post $0.18 Earnings Per Share” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at www.tickerreport.com/banking-finance/3349149/brokerages-expect-china-automotive-systems-caas-to-post-0-18-earnings-per-share.html.

Top 10 Warren Buffett Stocks To Buy Right Now: Mitsubishi Corporation (MSBHY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Automotive is moving well, up 14% y/y driven by HD Radio tech. The latter is included in an A list of important models, including Tesla Model 3, the Mitsubishi (OTCPK:MSBHY) Mirage and the Nissan (OTCPK:NSANY) Rogue. Their connected radio solution is also coming along nicely.

  • [By SEEKINGALPHA.COM]

    Japanese trading company Itochu (OTCPK:ITOCY) has a tough act to follow – its own meaningful improvement over the past five years. The company was more willing than most of its Japanese trading peers to deemphasize commodity/resource businesses, and it moved fairly quickly here, building up non-resource businesses like its food, machinery, and finance operations. Those moves have led to better ROE and cash flow margin performance versus its peers, and Itochu shares have done well relative to peers like Mitsui (OTCPK:MITSY), Mitsubishi (OTCPK:MSBHY), Marubeni (OTCPK:MARUY), and Sumitomo (OTCPK:SSUMY) over that time.

  • [By SEEKINGALPHA.COM]

    Renault Nissan (OTC:RNSDF) (NSANY)/Mitsubishi (OTCPK:MSBHY) (MMTOF)

    On December 20, Green Car Reports reported: “Mitsubishi electric cars to use Nissan-Renault platforms.” Remember Mitsubishi has the US$22,995 all-electric 16 kWh iMiEV coming out in 2017.

Top 10 Warren Buffett Stocks To Buy Right Now: Cerus Corporation(CERS)

Advisors’ Opinion:

  • [By Paul Ausick]

    Cerus Corp. (NASDAQ: CERS) dropped about 27% Tuesday to post a new 52-week low of $2.19 after closing at $3.00 on Monday. The stock’s 52-week high is $7.64. Volume was about 5 times the daily average of around 1.6 million shares. The company had no specific news.

  • [By Lisa Levin]

    Friday afternoon, healthcare shares gained by 0.99 percent. Meanwhile, top gainers in the sector included Cerus Corporation (NASDAQ: CERS), and Air Methods Corp (NASDAQ: AIRM).

Top 10 Warren Buffett Stocks To Buy Right Now: Scana Corporation(SCG)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was SCANA Corp. (NYSE: SCG) which rose over 22% to $47.71. The stocks 52-week range is $37.10 to $73.81. Volume was about 19 million compared to its average volume of 2 million.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Monday was SCANA Corp. (NYSE: SCG) which traded down over 6% at $42.38. The stocks 52-week range is $41.15 to $74.99. Volume was over 3.5 million versus the daily average of 2.2 million shares.

  • [By Lisa Levin]

    In trading on Monday, utilities shares were relative laggards, down on the day by about 0.43 percent. Meanwhile, top losers in the sector included SCANA Corporation (NYSE: SCG), down 2 percent, and FirstEnergy Corp. (NYSE: FE), down 2 percent.

Top 10 Warren Buffett Stocks To Invest In 2018

On Feb. 17, 2017, the U.S. total market cap / gross domestic product ratio reached 130%, a critical milestone as valuations remain significantly overvalued. Most of Warren Buffett (Trades, Portfolio)’s portfolio holdings as of Dec. 31, 2016, have price-sales valuations greater than the 80th percentile of the industry. Such companies include The Coca-Cola Co. (NYSE:KO), International Business Machines Corp. (NYSE:IBM), Delta Air Lines Inc. (NYSE:DAL), Apple Inc. (NASDAQ:AAPL) and Southwest Airlines Co. (NYSE:LUV).

Buffett indicator reaches critical milestone

Buffett pointed out that the ratio of the Wilshire 5000 full-cap index over the gross domestic product is “probably the best single measure of where valuations stand at any given moment.” The total market index is currently $24513.4 billion, about 130% of the last reported U.S. GDP. Such market valuations seldom appeared since the dot-com bubble of 2000, when the Buffett indicator reached nearly 150%. Figure 1 shows the historical trendline of the Buffett indicator since 1970.

Top 10 Warren Buffett Stocks To Invest In 2018: Fresh Del Monte Produce, Inc.(FDP)

Advisors’ Opinion:

  • [By Lee Jackson]

    The man at the top of Fresh Del Monte Produce Inc. (NYSE: FDP) wasselling stock last week. Chairman and CEO Mohammad Abu-Ghazaleh shed a block of 50,000 shares at prices that ranged from $57.85 to $58.46 apiece. The total was listed at $2.9 million. The stock ended the weekat $58.31, in a 52-week range of $41.70 to $66.86. The consensus price target is $70.30.

  • [By John Udovich]

    Thanksgiving is almost here and aside from featuring a turkey, most Thanksgiving dinners will include items from a range of consumer stocks including Campbell Soup Company (NYSE: CPB), Kraft Heinz Co (NASDAQ: KHC), Fresh Del Monte Produce Inc (NYSE: FDP) and McCormick & Company (NYSE: MKC) along with aThanksgiving turkey from Hormel Foods Corporation (NYSE: HRL)or Seaboard Corporation (NYSEAMEX: SEB). According tothe American Farm Bureau Federation,a classic Thanksgiving dinner will cost$49.87 for a gathering of 10 orjust under $5 per person down from 2015s all-time high of $50.11.

Top 10 Warren Buffett Stocks To Invest In 2018: Orbital ATK, Inc.(OA)

Advisors’ Opinion:

  • [By Rich Smith]

    While Trump’s nuclear tweet appears to have taken some folks off guard, the fact is that the U.S. has been planning a major upgrade and refurbishmentof its nuclear arsenal for quite some time — since at least the early years of the second Obama administration, in fact. As far back as three years ago, we were writing about a U.S. Air Force effort to begin upgrading the nation’s aging fleet of Minuteman III intercontinental ballistic missiles — a contract that Aerojet Rocketdyne (NYSE:AJRD), among others, is counting on to juice its rocket revenues. Rival rocket scientist Orbital ATK (NYSE:OA) is bidding on the same contract, and whether it’s Aerojet or Orbital that eventually ends up winning this piece of the nuclear rearmament project, there should be money aplenty to go around.

  • [By Rich Smith]

    Orbital ATK (NYSE:OA) occupies a charmed space in the U.S. market for putting satellites in, er, space.

    At one end of the space launch continuum, you have United Launch Alliance, whose Delta IV Heavy launch vehicle, developed by Boeing (NYSE:BA), can put a payload massing in excess of 28 tonsinto orbit in a single launch — at a cost of $350 million.At the other end, new space start-ups like Vector Space are promising to launch a new generation of small satellites into low-earth orbit for prices as little as $2 million a shot. But what about the middle?

  • [By Rich Smith]

    Now consider that as of the last report, Americans owned 265 million guns — but fewer than 1 million silencers. That’s a huge market that American Outdoor Brands and Sturm, Ruger would love to sell into. Easing restrictions on silencer sales could have follow-on effects, too. Granting easier access to suppressors could reduce noise complaints at open-air shooting ranges, making it easier for such businesses to open, which would attract more customers, resulting in more ammunition being used, resulting in more ammunition being sold, resulting in more sales (and profits) for ammo makers such as Olin Corp (NYSE:OLN), Vista Outdoor (NYSE:VSTO), and Orbital ATK (NYSE:OA).

  • [By Lisa Levin]

    Defense giant Northrop Grumman Corporation (NYSE: NOC) confirmed Monday it will buy Orbital ATK Inc (NYSE: OA), the maker of the Pegasus rocket and a vast array of other aerospace and defense systems, in a $9.2 billion deal.

  • [By Jim Robertson]

    Last Monday, U.S. defense contractor Northrop Grumman Corporation (NYSE: NOC) announced it would buy Orbital ATK Inc (NYSE: OA), a direct Aerojet Rocketdyne competitor,for about $7.8 billion (a 22% premium to Orbital’s Friday close) in a deal thatwill give it greater access to lucrative government contracts and expand its arsenal of missile defense systems and space rockets. While Northrop already has a significant presence in payloads, it has not had launcher capability, an area that Orbital brings for both space and missile defense. Orbital also has contracts with NASA and the U.S. Army. The all-cash transaction is the biggest in the defense sector in two years and comes ahead of planned upgrades of U.S. ballistic systems (as the saber rattling by North Korea continues), which are expected to drive demand for missiles.

Top 10 Warren Buffett Stocks To Invest In 2018: Alnylam Pharmaceuticals Inc.(ALNY)

Advisors’ Opinion:

  • [By Brian Orelli]

    Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.

  • [By Cory Renauer]

    Treating diseases that have a genetic component by altering the expression of the responsible genes is a promising new field of medicine, but it has been much less straightforward than biopharmaceutical companies had expected. Two contenders in this area, Alnylam Pharmaceuticals (NASDAQ:ALNY) and Ionis Pharmaceuticals (NASDAQ:IONS), saw a mix of setbacks and success in 2016.

  • [By Chris Dier-Scalise]

    On Thursday, the Vetr crowd downgraded Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) from 4.5 stars (Strong Buy), which was issued two days ago, to 3.5 stars (Hold). Crowd sentiment for Alnylam at the time of the downgrade was edging positive, with 66 percent of Vetr user rating bullish.

  • [By Ben Levisohn]

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

  • [By Lisa Levin]

    Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares shot up 53 percent to $114.87 after the company impressed investors with encouraging data from a phase 3 clinical trial. Alnylam, a company dedicated towards treating a wide range of debilitating diseases through ribonucleic acid (RNA) interference (RNAi) therapeutics, said after Tuesday's market close that a phase 3 study called APOLLO met its primary efficacy endpoint and all secondary endpoints.

Top 10 Warren Buffett Stocks To Invest In 2018: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

  • [By Teresa Rivas]

    Jazz Pharmaceuticals (JAZZ) is trading up nearly 9% Thursday, thanks to its settlement with Hikma Pharmaceuticals over the firms patent dispute.

    Pixabay

    As part of the agreement, Hikma will get to sell a generic version of the drug in question, narcolepsy treatment Xyrem, in 2023, for up to five years, while Jazz will get royalties on those sales.

    Janney Montgomery Scotts Ken Trbovich upgraded the shares from Neutral to Buy on the news, and also increased his price target from $138 to $175. From his note:

    While this comes about three years earlier than previous settlements with other generic filers, it eliminates the risk of an earlier launch. Six months thereafter Hikma may launch its own generic and others may potentially be able to launch as well. Importantly, Jazz will receive a meaningful royalty on sales, retain the right to launch its own AG, and can authorize other AGs after the initial 6-month Hikma period.

    Jazz shares are up 8.9% to $153.2o at recent check.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Ben Levisohn]

    Jazz Pharmaceuticals (JAZZ) has jumped 6.3% to $149.45 after settling a patent dispute.

    CarMax (KMX) gained 2.4% to $58 after beating earnings and sales forecasts.

Top 10 Warren Buffett Stocks To Invest In 2018: Black Diamond, Inc.(BDE)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the week, our Under the Radar Moversnewsletter suggested small cap sporting & outdoor goods stock Black Diamond Inc (NASDAQ: BDE) as a short/bearish trade:

Top 10 Warren Buffett Stocks To Invest In 2018: TherapeuticsMD, Inc.(TXMD)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    On the show’s “Lightning Round” segment, Jim Cramer was bullish on Penn National Gaming (PENN) , KeyCorp (KEY) and TherapeuticsMD (TXMD) .

    Quiet Breakups

  • [By ]

    TherapeuticsMD (Nasdaq: TXMD) is a pharmaceutical company with an exclusive focus on products for women and advanced hormone therapies. Biotech stocks are often a target for short sellers because of the uncertainty around drug development and approvals.

Top 10 Warren Buffett Stocks To Invest In 2018: State Bank Financial Corporation.(STBZ)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    J P Morgan Chase & Co (NYSE: JPM): Free Stock Analysis Report
     
    Comerica Incorporated (NYSE: CMA): Free Stock Analysis Report
     
    Wells Fargo & Company (NYSE: WFC): Free Stock Analysis Report
     
    Citigroup Inc. (NYSE: C): Free Stock Analysis Report
     
    Wintrust Financial Corporation (NASDAQ: WTFC): Free Stock Analysis Report
     
    Synovus Financial Corp. (NYSE: SNV): Free Stock Analysis Report
     
    State Bank Financial Corporation. (NASDAQ: STBZ): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Top 10 Warren Buffett Stocks To Invest In 2018: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    When I began writing this, I had a 76% unrealized gain on my position in Aphria Inc (OTCQB:APHQF). It’s crunch time. This is where most sane individuals would be jumping ship and taking earnings. Me? I’m tempted to stay. Aphria has big things happening. The ramifications of the their developing marketplace in Canada are giving Aphria the potential to start reeling in some serious revenues. Furthermore, they have significant holdings in the United States that offer upside if regulatory hurdles don’t get in the way.

  • [By Keith Speights]

    As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria (NASDAQOTH:APHQF),Aurora Cannabis (NASDAQOTH:ACBFF), Medical Marijuana,Inc.(NASDAQOTH:MJNA), and even GW Pharmaceuticals (NASDAQ:GWPH) in the process?

  • [By Sean Williams]

    This rapid growth in legal pot has create quite the demand for marijuana stocks. The seven largest marijuana stocks by market cap have all put on a show over the past couple of years. Here are those seven “green giants” listed with their market caps as of March 17, 2017, along with their trailing one-year total returns.

    GW Pharmaceuticals (NASDAQ:GWPH): $3.0 billion, up 64% Canopy Growth Corp. (NASDAQOTH:TWMJF): $904 million, up 259% Aphria (NASDAQOTH:APHQF) $440 million, up 381% Aurora Cannabis (NASDAQOTH:ACBFF): $482 million, up 299% AXIM Biotechnologies (NASDAQOTH:AXIM): $562 million, up 1,720% Corbus Pharmaceuticals (NASDAQ:CRBP): $450 million, up 431% Medical Marijuana (NASDAQOTH:MJNA): $221 million, up 254%

    As you can see, these are some hefty valuations — and some exceptionally strong moves higher on the heels of marijuana’s expansion. With the exception of GW Pharmaceuticals, every one of the largest marijuana stocks has at least tripled in value over the trailing 12 months, with cannabinoid-based drug developer AXIM Biotechnologies skyrocketing more than 1,700%!

  • [By SEEKINGALPHA.COM]

    Aphria (OTCQB:APHQF) just did something very unusual and frankly caught us by surprise. The company announced that it is amending its previously announced transaction with Nuuvera (OTC:NUUVF) by which the cash portion of the consideration will be lowered from $1.00 to $0.60. The announcement surprised us as our past experience suggested that lowering purchase price post-deal announcement is extremely uncommon, especially in the absence of major negative developments at the target. Simultaneously, Nuuvera announced that it is acquiring the remaining 49% minority interest in Avanti Rx Analytics from a minority shareholder for $43 million. Avanti is a subsidiary of Nuuvera that provides research and testing services for cannabis companies. Nuuvera claimed that the reduced cash offer helps fund its acquisition, which makes no sense for us.

  • [By Javier Hasse]

    Also quite recently, Benzinga asked Alan Brochstein, founding partner at New Cannabis Ventures and founder at 420 Investor, about plays in the marijuana industry against such an uncertain backdrop. The expert mentioned a few Canadian Licensed Producers, including AURORA CANNABIS IN COM NPV (OTC: ACBFF), APHRIA INC NPV (OTC: APHQF), METTRUM HEALTH COR COM NPV (OTC: MQTRF), ORGANIGRAM HLDGS I COM NPV (OTC: OGRMF), SUPREME PHARMACEUT COM NPV (OTC: SPRWF) and CANOPY GROWTH CORP COM NPV (OTC: TWMJF), as well as “the only” biotech stock in the space, GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH).

Top 10 Warren Buffett Stocks To Invest In 2018: Mitel Networks Corporation(MITL)

Advisors’ Opinion:

  • [By Lisa Levin]

    ShoreTel Inc (NASDAQ: SHOR) shares shot up 28 percent to $7.47. Mitel Networks Corp (NASDAQ: MITL) announced plans to acquire Shortel for $7.50 per share in cash.

Top 10 Warren Buffett Stocks To Invest In 2018: PetroChina Company Limited(PTR)

Advisors’ Opinion:

  • [By Money Morning News Team]

    PetroChina Co. Ltd. (NYSE ADR: PTR) is China’s largest oil company with a market cap of $216.52 billion. PTR is partially owned by the Chinese government.

free penny stock picks

New York, NY, based Investment company Orbimed Advisors Llc buys Anthem, Alexion Pharmaceuticals, Aetna, Humana, Synergy Pharmaceuticals, Merck, Pfizer, HCA Holdings, Eli Lilly and Co, Momenta Pharmaceuticals, sells WellCare Health Plans, Molina Healthcare, Express Scripts Holding Co, Impax Laboratories, Zimmer Biomet Holdings during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Orbimed Advisors Llc. As of 2016-12-31, Orbimed Advisors Llc owns 124 stocks with a total value of $7.8 billion. These are the details of the buys and sells.

New Purchases: ANTM, MNTA, BGNE, SEM, CRSP, TSRO, ROKA, PTCT, CLSD, NVLN, Added Positions: ALXN, AET, HUM, SGYP, MRK, PFE, HCA, LLY, VRTX, GWPH, Reduced Positions: MOH, ZBH, ABBV, GILD, BLUE, ILMN, TEVA, UNH, IRWD, BMY, Sold Out: WCG, ESRX, IPXL, EXEL, OPHT, CI, CYNA, SRPT, ARWR, SAGE,

For the details of ORBIMED ADVISORS LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ORBIMED+ADVISORS+LLC

free penny stock picks: Atlantia S.p.A. (ATASF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Atlantia (ATASF) (AT.IM), Eiffage (OTCPK:EFGSY) (FGR.FP), Ferrovial (OTC:FRRVF) (FER.SM), Albertis (OTC:ABFOF) (ABE.SM) and Vinci (OTCPK:VCISF) (DG.FP)

free penny stock picks: Universal Health Services, Inc.(UHS)

Advisors’ Opinion:

  • [By David Zeiler]

    Fear that expense could return if Obamacare is repealed hammered hospital stocks on Nov. 9. HCA Holdings Inc. (NYSE: HCA) fell almost 11%. Universal Health Services Inc. (NYSE: UHS) slipped nearly 7%. And Tenet Healthcare Corp. (NYSE: THC) plummeted almost 25%.

  • [By Ben Levisohn]

    Universal Health Services (UHS) slumped to the bottom of the S&P 500 today after getting downgraded by Raymond James.

    Pixabay

    Universal Health Servicesdropped 6.8% to $101.55 today, while the S&P 500 fell 0.8% to 2,253.28.

    Raymond James analyst John Ransom and team explain why they cut Universal Health Services to Market Perform from Outperform:

    We are lowering our rating onUniversal Health Services to a Market Perform (from an Outperform) due to an escalation in events surrounding last weeks Buzzfeed article. Last Friday (12/9), Senator Grassley, Chair of the Judiciary Committee, sent a letter…to the office of inspector general regarding details of the current federal investigation into Universal Health Services. Specifically, the letter rehashes the Buzzfeed article and requests an update on the investigation by Dec. 23. Our view is that – even ifUniversal Health Services management is correct on the legalities – we think the entrance of the venerable Senator Grassley into the mix takes the political risk to a more dangerous level. Plus – even if “suicide ideation” doesn’t generate additional revenues per admission, we think it’s possible that the heightened political scrutiny could invite more caution and/or red tape into the admissions process – either externally or from self-policing. Add in the ongoing OIG investigation, and we think the risk-reward is no longer compelling.

    Universal Health Services’ market capitalization fell to $9.8 billion today from $10.6 billion yesterday. It reported net income of $680 million on sales of $9 billion in 2015.

  • [By Benzinga News Desk]

    Goldman Sachs (NYSE: GS) has at least one billion reasons to hope President Trump’s paring back of Dodd-Frank will include the Volcker Rule: Link

    ECONOMIC DATA
    10:30 a.m. Dallas Fed Manufacturing Business Index
    11:30 a.m. 6-Month Bill Auction
    11:30 a.m. 3-Month Bill Auction
    1 p.m. 2-Year Note Auction
    1:15 p.m. Chicago Fed President Evans Speaks
    6:30 p.m. FOMC Member Kaplan Speaks
    ANALYST RATINGS
    Piper Jaffray upgraded Best Buy Co (NYSE: BBY) from Neutral to Overweight
    Wells Fargo upgraded Allscripts Healthcare (NASDAQ: MDRX) from Market Perform to Outperform
    Mizuho upgraded Universal Health Service (NYSE: UHS) from Neutral to Buy
    Piper Jaffray downgraded The Michaels Companies (NASDAQ: MIK) from Overweight to Neutral
    JMP Securities downgraded KB Home (NYSE: KBH) from Market Outperform to Market Perform
    Raymond James downgraded Sierra Wireless Inc. (NASDAQ: SWIR) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Ben Levisohn]

    Universal Health Services (UHS), yesterday’s biggest loser, soared to the top of the S&P 500 today as it rebounded from the massive selloff.

    Agence France-Presse/Getty Images

    Universal Health Servicesgained 6.9% to $108.57 today, while the S&P 500 rose 0.4% to 2,262.03.

    Weakness in Universal Health Services began when Buzzfeed ran an article last week, contending the companys psychiatric hospitals put profits ahead of people. Yesterday, it tumbled when Raymond James cut its rating on the stock due to problems that could be caused by a potential Senate investigation.

    Universal Health Services’ market capitalization rose to $10.5 today from $9.8 billion yesterday, nearly recouping its drop from $10.6 billion on Dec. 13.

    It reported net income of $680 million on sales of $9 billion in 2015.

  • [By Ben Levisohn]

    Universal Health Services (UHS) tumbled to the bottom of the S&P 500 today after BuzzFeed published an investigative story alleging that the company’s psychiatric hospitals put profits ahead of people.

    Getty Images

    Shares of Universal Health Services dropped 12% to$111.30 today, while the S&P 500 rose 1.3% to 2,241.35, a record high.

    Universal Health Services’ stock had been minding its business for most of the day–it was up 1.1% at $127.76 at 3:10 p.m. today–when the story by BuzzFeed’s Rosalind Adams went live. Here’s the gist:

    Millwood Hospital is part of Americas largest psychiatric hospital chain, Universal Health Services, or UHS. Its more than 200 psychiatric facilities across the country admitted nearly 450,000 patients last year. The result was almost $7.5 billion in revenues from inpatient care last year and profit margins of around 30%. More than a third of the companys overall revenue from both medical hospitals and psychiatric facilities comes from taxpayers through Medicare and Medicaid.

    A yearlong BuzzFeed News investigation based on interviews with 175 current and former UHS staff, including 18 executives who ran UHS hospitals; more than 120 additional interviews with patients, government investigators, and other experts; and a cache of internal documents raises grave questions about the extent to which those profits were achieved at the expense of patients.

    Universal Health Services market capitalization dropped to $10.7 billion today from $12.3 billion yesterday. It reported net income of $680 million on sales of $9 billion in 2015.

free penny stock picks: (LGEAF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    However, Apple is turning to LG (OTC:LGEAF) and the Herald reports that Apple is even considering investing in a future plant in China to build flexible displays. It’s thought that the bendable displays could be available as early as 2019.

  • [By SEEKINGALPHA.COM]

    Coherent’s ELA deposition technology for LTPS backplane isn’t used in OLED TVs, where LG (OTC:LGEAF) uses metal oxide backpanes. There was some worry by analysts whether that technology could migrate to the smartphone panel market which CEO Ambroseo could not dispel entirely, but he argued that it has not been demonstrated suitable for handsets or battery-powered devices at this point.

  • [By SEEKINGALPHA.COM]

    There are other areas of smartphone innovation pursued by other companies besides Apple. The development of OLED screens has been a significant innovation pursued mainly by Korean giants Samsung (OTC:SSNLF) and LG (OTC:LGEAF). It is now being reported that Samsung and LG will introduce smartphones with foldable OLED screens this year.

  • [By SEEKINGALPHA.COM]

    The importance of cellular connectivity for wearables, particularly for smartwatches, has been a theme of mine since last year, and I’m glad to see other analysts and organizations starting to pick up on it. I’ve discussed Qualcomm’s (NASDAQ:QCOM) development of the Snapdragon Wear SOC that manufacturers are using for Android Wear 2 smartwatches with LTE connectivity, such as the LG Watch Sport (OTC:LGEAF). Such watches provide voice calling and cellular data connections and anticipate the future direction of the smartwatch.

free penny stock picks: HSBC Holdings plc(HSBC)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Up first on our list of financial sector breakout trades is $156 billion global bank HSBC Holdings plc (HSBC) . Don’t get fooled by the headline numbers in HSBC this year – shares may be hovering around breakeven year-to-date, but they’re up more than 35% from their April lows. And after tracking sideways for the last couple of months, HSBC is back in breakout mode this week.

  • [By Elizabeth Balboa]

    Here are the top 10 financial bodies investing in lobbying in 2017:

    American Bankers Association: $5.6 million
    Securities Industry & Financial Market Association: $3.5 million
    Financial Services Roundtable: $3.0 million
    Independent Community Bankers of America: $2.7 million
    Association of International CPAs: $2.6 million
    Citigroup Inc (NYSE: C): $2.5 million
    Investment Company Institute: $2.4 million
    S&P Global Inc (NYSE: SPGI): $2.4 million
    Credit Union National Association: $2.4 million
    HSBC Holdings plc (ADR) (NYSE: HSBC): $2.4 million

    Dozens of others spent more than $1 million, including Ally Financial Inc (NYSE: ALLY), Visa Inc (NYSE: V) and Navient Corp (NASDAQ: NAVI).

  • [By Money Morning News Team]

    And the Aramco IPO is making progress. On Feb. 7, the Saudi Arabian oil company hired Moelis & Co. (NYSE:MC) as its IPO advisor. Then on Feb. 21, the company hired the lead underwriters for the IPO. Wall Street stalwarts JPMorgan Chase & Co. (NYSE: JPM), Morgan Stanley (NYSE: MS), and HSBC Holdings Plc. (NYSE ADR: HSBC) won the lucrative underwriting contracts.

free penny stock picks: Kona Grill Inc.(KONA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Kona Grill Inc (NASDAQ: KONA) was down, falling around 25 percent to $2.00 after the company reported downbeat quarterly results.

    Commodities

free penny stock picks: Black Diamond, Inc.(BDE)

Advisors’ Opinion:

  • [By Jim Robertson]

    At the beginning of the week, our Under the Radar Moversnewsletter suggested small cap sporting & outdoor goods stock Black Diamond Inc (NASDAQ: BDE) as a short/bearish trade: